MariMed Promotes Ryan Crandall to Chief Commercial Officer
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Crandall will oversee the company's commercial strategy, including Sales, Marketing, Product Development, and Retail Operations.
Crandall previously served as MariMed's Chief Revenue Officer since July 2022 and held positions as Chief Products Officer and SVP, Sales. He entered the cannabis industry in 2014 as co-creator of Betty's Eddies™, a cannabis-infused chews brand that was later acquired by MariMed. Before joining MariMed in 2018, he held executive positions in cybersecurity and software corporations, including RSA Security and EMC2.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha promosso Ryan Crandall a Chief Commercial Officer, con effetto immediato. Nel suo nuovo ruolo, Crandall supervisionerà la strategia commerciale dell'azienda, inclusi Vendite, Marketing, Sviluppo Prodotti e Operazioni di Vendita al Dettaglio.
Crandall ha precedentemente ricoperto il ruolo di Chief Revenue Officer di MariMed da luglio 2022 e ha ricoperto posizioni come Chief Products Officer e SVP, Vendite. È entrato nel settore della cannabis nel 2014 come co-creatore di Betty's Eddies™, un marchio di caramelle infuse di cannabis successivamente acquisito da MariMed. Prima di unirsi a MariMed nel 2018, ha ricoperto ruoli esecutivi in aziende di cybersecurity e software, tra cui RSA Security ed EMC2.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) ha promovido a Ryan Crandall como Chief Commercial Officer, con efecto inmediato. En su nuevo rol, Crandall supervisará la estrategia comercial de la empresa, incluyendo Ventas, Marketing, Desarrollo de Productos y Operaciones de Venta al por Menor.
Crandall anteriormente se desempeñó como Chief Revenue Officer de MariMed desde julio de 2022 y ocupó puestos como Chief Products Officer y SVP, Ventas. Se unió a la industria del cannabis en 2014 como co-creador de Betty's Eddies™, una marca de caramelos infusionados con cannabis que fue adquirida posteriormente por MariMed. Antes de unirse a MariMed en 2018, ocupó posiciones ejecutivas en empresas de ciberseguridad y software, incluyendo RSA Security y EMC2.
마리메드 주식회사 (CSE: MRMD) (OTCQX: MRMD)는 라이언 크랜달을 최고 상업 책임자로 즉시 승진시켰습니다. 그의 새로운 역할에서 크랜달은 회사의 상업 전략을 감독하며, 여기에는 판매, 마케팅, 제품 개발 및 소매 운영이 포함됩니다.
크랜달은 2022년 7월부터 마리메드의 최고 수익 책임자로 재직했으며, 최고 제품 책임자 및 SVP, 판매 등의 직책을 맡았습니다. 그는 2014년에 베티의 에디스™라는 대마초-infused 캔디 브랜드의 공동 창립자로 대마초 산업에 진입했습니다. 2018년 마리메드에 합류하기 전에 그는 RSA Security와 EMC2를 포함한 사이버 보안 및 소프트웨어 기업에서 임원직을 수행했습니다.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) a promu Ryan Crandall au poste de Chief Commercial Officer, avec effet immédiat. Dans son nouveau rôle, Crandall supervisera la stratégie commerciale de l'entreprise, y compris les ventes, le marketing, le développement de produits et les opérations de vente au détail.
Crandall a précédemment été Chief Revenue Officer de MariMed depuis juillet 2022 et a occupé des postes de Chief Products Officer et SVP, Ventes. Il a rejoint l'industrie du cannabis en 2014 en tant que co-créateur de Betty's Eddies™, une marque de bonbons infusés au cannabis qui a ensuite été acquise par MariMed. Avant de rejoindre MariMed en 2018, il a occupé des postes exécutifs dans des entreprises de cybersécurité et de logiciels, y compris RSA Security et EMC2.
MariMed Inc. (CSE: MRMD) (OTCQX: MRMD) hat Ryan Crandall mit sofortiger Wirkung zum Chief Commercial Officer befördert. In seiner neuen Rolle wird Crandall die kommerzielle Strategie des Unternehmens überwachen, einschließlich Vertrieb, Marketing, Produktentwicklung und Einzelhandelsoperationen.
Crandall war zuvor seit Juli 2022 Chief Revenue Officer bei MariMed und hatte Positionen als Chief Products Officer und SVP, Vertrieb inne. Er trat 2014 in die Cannabisbranche ein, als er Mitbegründer von Betty's Eddies™ wurde, einer Marke für cannabis-infused Bonbons, die später von MariMed übernommen wurde. Bevor er 2018 zu MariMed kam, hatte er Führungspositionen in Cybersecurity- und Softwareunternehmen, darunter RSA Security und EMC2.
- Strategic promotion of experienced executive with proven track record in product development and sales
- Internal promotion demonstrates strong succession planning and talent retention
- Leadership continuity maintained as Crandall has been with company since 2018
- None.
NORWOOD, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or “Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer has promoted Ryan Crandall to Chief Commercial Officer, effective immediately. In his new role, Mr. Crandall will lead the Company’s commercial strategy and activities, including Sales, Marketing, Product Development, and Retail Operations. He has served as MariMed’s Chief Revenue Officer since July 2022, and prior was the Company’s Chief Products Officer and SVP, Sales for four years. Mr. Crandall will continue to report to MariMed CEO Jon Levine.
“Ryan has been a driving force behind creating our innovative and trusted portfolio of brands and establishing them as top sellers in our core markets,” said Mr. Levine. “He has also guided our efforts to deliver an exceptional customer experience at our retail locations. His promotion to Chief Commercial Officer is well-deserved and I look forward to his continued contributions to value generation for our customers and shareholders.”
Mr. Crandall entered the cannabis industry in 2014 when he co-created Betty’s Eddies™, a brand of all-natural, cannabis-infused chews that MariMed acquired prior to his joining the company in 2018. Prior, he held a series of executive positions with increasing sales responsibilities in major cybersecurity and software corporations, including RSA Security and EMC2.
“I am honored and excited to step into the role of Chief Commercial Officer at MariMed,” said Mr. Crandall. “Being a part of this great company, with its award-winning brands, dedication to strategic growth initiatives, and commitment to its mission of improving lives, has been a fantastic journey. I’m eager to deepen my collaboration with our talented team, building on our collective success to strengthen MariMed’s position as a leading cannabis products company.”
About MariMed
MariMed Inc. is a leading multi-state cannabis operator, known for developing and managing state-of-the-art cultivation, production, and retail facilities. Our award-winning portfolio of cannabis brands, including Betty's Eddies™, Bubby’s Baked™, InHouse™, Nature’s Heritage™, and Vibations™, sets us apart as an industry leader. These trusted brands, crafted with quality and innovation, are recognized and loved by consumers across the country. With a commitment to excellence, MariMed continues to drive growth and set new standards in the cannabis industry. For additional information, visit www.marimedinc.com.
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
FAQ
What is Ryan Crandall's new role at MariMed (MRMD) as of April 2025?
What was Ryan Crandall's previous position at MariMed (MRMD) before becoming CCO?
What is Ryan Crandall's connection to Betty's Eddies cannabis brand?
When did Ryan Crandall join MariMed (MRMD)?
